Clinical Snippets  by unknown
clinical snippets
© 2011 The Society for Investigative Dermatology www.jidonline.org 999
The Risk of Death  
in Psoriasis
Although studies of specialized 
populations identified an 
association of psoriasis with an 
increased risk of cardiovascular 
disease (CVD), possibly due to 
increased inflammation, Stern 
and Huibregtse found that 
exceptionally severe psoriasis 
was, indeed, associated with 
significantly increased mortality 
but not specifically with 
increased cardiovascular risk. 
These researchers performed 
a 30-year prospective study of 
patients with severe psoriasis 
and determined cause-
specific mortality among 
patients. These results do not 
support the previously posed 
hypothesis that severe psoriasis 
is an independent risk factor for 
CVD. See page 1159
Melanoma Mutation 
in China
Somatic mutations in BRAF, 
especially T1799A, have 
been detected frequently in 
malignant melanoma (MM) and 
benign melanocytic nevi (MN). 
Qi and colleagues examined 
379 cases of MN and 195 cases 
of MM from Chinese Han from 
three distinct geographical 
regions in China. BRAF T1799A 
mutations were common in 
Chinese MN. A significant 
difference in mutation rates 
was observed among the 
geographical regions, with 
acquired and congenital MN 
in regions with higher UV 
intensity—a known risk factor 
for melanoma—having higher 
mutation rates. Interestingly, 
this mutation was less 
frequently detected in MM, 
suggesting that this mutation is 
not necessarily associated with 
malignant transformation.  
See page 1129
Molecular End Points
Quantitative molecular end points are 
necessary to monitor the effectiveness 
of test agents in clinical trials. Because 
gene-specific siRNAs aimed at mutations 
in the keratin 6a (K6a) gene (KRT6A) have 
been evaluated for safety in phase Ib clin-
ical trials for treatment of pachyonychia 
congenita, Hickerson and colleagues 
developed a quantitative RT-PCR assay 
to measure mutant versus wild-type K6a 
mRNA levels in skin samples and skin 
callus shavings. Single-nucleotide differences between K6a wild-type and p.Asn171Lys 
mutant mRNAs were efficiently differentiated by this assay, suggesting that these meth-
ods may be useful for measuring end points in future clinical trials. See page 1029
Mutation Acquisition
The advent of molecular genetics and the identifi-
cation of genes that, when mutated, cause pachy-
onychia congenita (PC) (KRT6A, KRT6B, KRT16, 
and KRT17) offer a feasible classification system 
for patients. Wilson and colleagues identified 21 
novel mutations and 22 known mutations during 
analysis of 90 new families with PC. In combi-
nation with previously reported cases, this large 
mutational dataset provides mutation location, 
frequency of mutations, and types of mutations 
and allows for genotype–phenotype studies. The 
identification of mutation hotspots may be useful 
for the development of personalized PC treatment. 
See page 1018
Population Differences
Psoriasis is more common in individuals 
of European descent than in those of Asian 
descent. Associations among psoriasis, the 
PSORS1 locus that contains HLA-Cw6, and 
deletion of two late cornified envelope genes 
(LCE3C_LCE3B-del) have been demonstrated 
for multiple populations. An examination of 
13 cohorts from 12 populations (9 European 
and 3 Asian) by Riveira-Muñoz and col-
leagues confirmed that LCE3C_LCE3B-del is 
a common genetic susceptibility factor for 
psoriasis in European populations and identified such an association in some Asian 
populations. Epistatic effects between the HLA-Cw6 locus and the deletion were 
observed in some European populations but not in the Asian populations, underscoring 
the need to perform genetic risk factor analysis in multiple populations. See page 1105
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